Composition and method for improving sleep duration and quality
First Claim
Patent Images
1. A composition comprising:
- (a) a first component selected from one or more of the following;
collagen, a gelatin peptide, or the amino acid glycine;
wherein said first component has a molecular weight less than 3500 Dalton;
(b) a second component comprising L-theanine;
(c) a third component comprising lactucopicrin, deoxylactucopicrin, or another lactucopicrin derivative;
(d) a fourth component comprising hyaluronic acid;
(e) a fifth component comprising epigallocatechin gallate; and
(f) a sixth component comprising quinic acid;
wherein;
said composition is supplied in aqueous solution or aqueous suspension, or said composition is supplied as a powder that can be reconstituted into an aqueous solution or an aqueous suspension;
wherein the concentrations of the components of the aqueous solution or aqueous suspension are such that 30-60 mL of the aqueous solution or aqueous suspension supplies one dose that comprises;
(i) 0.5 to 12 g collagen peptide, or 0.5 to 5 g glycine as amino acid;
i.e., all or part of said first component;
(ii) a tea (Camellia sinensis) extract containing 100 to 500 mg theanine, and 50 to 300 mg epigallocatechin gallate;
i.e., all or part of said second and fifth components; and
(iii) 1 to 10 g chicory (Cichorium intybus) extract containing lactucopicrin, deoxylactucopicrin, or another lactucopicrin;
i.e., all or part of said third component;
and wherein;
said composition has the property that, if one dose of said composition is consumed orally by a human, one or more of the following will be improved;
onset of sleep, sleep depth, sleep quality, sleep duration, sleep apnea, or fatigue during the waking part of the day.
1 Assignment
0 Petitions
Accused Products
Abstract
An intervention for sleep disorders comprises: collagen, a gelatin peptide, or the amino acid glycine; L-theanine; lactucopicrin, deoxylactucopicrin, or another lactucopicrin derivative; hyaluronic acid; epigallocatechin gallate; and quinic acid. The intervention helps regulate pro-inflammatory biomarkers that are often associated with insomnia development and progression. These biomarkers include cytokines and enzymes associated with tryptophan degradation. Inhibition of these enzymes and cytokines improves tryptophan availability and sleep quality, and allows individuals to sleep better with fewer side effects. The composition promotes high-quality, deep sleep.
-
Citations
5 Claims
-
1. A composition comprising:
-
(a) a first component selected from one or more of the following;
collagen, a gelatin peptide, or the amino acid glycine;
wherein said first component has a molecular weight less than 3500 Dalton;(b) a second component comprising L-theanine; (c) a third component comprising lactucopicrin, deoxylactucopicrin, or another lactucopicrin derivative; (d) a fourth component comprising hyaluronic acid; (e) a fifth component comprising epigallocatechin gallate; and (f) a sixth component comprising quinic acid; wherein; said composition is supplied in aqueous solution or aqueous suspension, or said composition is supplied as a powder that can be reconstituted into an aqueous solution or an aqueous suspension;
wherein the concentrations of the components of the aqueous solution or aqueous suspension are such that 30-60 mL of the aqueous solution or aqueous suspension supplies one dose that comprises;
(i) 0.5 to 12 g collagen peptide, or 0.5 to 5 g glycine as amino acid;
i.e., all or part of said first component;
(ii) a tea (Camellia sinensis) extract containing 100 to 500 mg theanine, and 50 to 300 mg epigallocatechin gallate;
i.e., all or part of said second and fifth components; and
(iii) 1 to 10 g chicory (Cichorium intybus) extract containing lactucopicrin, deoxylactucopicrin, or another lactucopicrin;
i.e., all or part of said third component;and wherein; said composition has the property that, if one dose of said composition is consumed orally by a human, one or more of the following will be improved;
onset of sleep, sleep depth, sleep quality, sleep duration, sleep apnea, or fatigue during the waking part of the day. - View Dependent Claims (2, 3, 4, 5)
-
Specification